0.97 USD
↗ 0.13 (15.33%)AT CLOSE (11:59 AM EDT)
TScan Therapeutics, Inc. Common Stock
TCRXNASDAQ • USD
0.91
↘ 0.05 (5.66%)
POST MARKET (AS OF 06:55 PM EDT)
Post Market
AS OF 06:55 PM EDT
0.91
↘ 0.05 (5.66%)
Market: CLOSED
Shares of TScan Therapeutics, Inc. Common Stock (TCRX) are trading at $0.97. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest TCRX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$0.85
High?$0.97
Low?$0.84
Prev. Close?$0.84
Volume?713.3K
Avg. Volume?533.3K
VWAP?$0.90
Rel. Volume?1.34x
Bid / Ask
Bid?$0.72 × 100
Ask?$1.16 × 100
Spread?$0.44
Midpoint?$0.94
Valuation & Ratios
Market Cap?63.4M
Shares Out?61.1M
Float?50.6M
Float %?82.9%
P/E Ratio?N/A
P/B Ratio?0.65
EPS?-$1.90
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Themes
Employees
142
Market Cap
54.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-16
Address
830 WINTER STREET
WALTHAM, MA 02451
Phone: 857-399-9500
WALTHAM, MA 02451
Phone: 857-399-9500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?50
Short Sent.?74
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.72Distress
Confidence?49%Low
Short InterestLow
Short % of Float?1.51%Low
Short Interest?762.5K
Days to Cover?1.9
Free Float50.6M
Avg Daily Volume392.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?6.65Strong
Quick Ratio?6.65Strong
Cash Ratio?6.41Strong
Debt/Equity?0.34Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.65CHEAP▾
Peers100
S&P97
P/S?6.94FAIR▾
Peers100
S&P17
P/FCF?N/A▾
EV/EBITDA?0.3CHEAP▾
Peers100
S&P97
EV/Sales?-3.50CHEAP▾
S&P97
Returns & Efficiency
ROE?-128.3%WEAK▾
S&P3
ROA?-61.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-124957000
Enterprise Value?$-32012708
Fundamentals ratios updated end of day